|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
OR_ocn879653104 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
140514s2013 paua ob 001 0 eng d |
040 |
|
|
|a UMI
|b eng
|e pn
|c UMI
|d IDEBK
|d GGVRL
|d GWM
|d DEBBG
|d COO
|d OCLCQ
|d OCLCF
|d OCLCO
|d CEF
|d OCLCA
|d AU@
|d OCLCO
|d OCLCA
|d UAB
|d STF
|d OCLCO
|d CASUM
|d OCLCA
|d OCLCO
|d OCLCQ
|d INARC
|d OCLCO
|
019 |
|
|
|a 864746994
|
020 |
|
|
|a 9781908818386
|
020 |
|
|
|a 1908818387
|
020 |
|
|
|a 9781306177061
|q (ebk)
|
020 |
|
|
|a 1306177065
|q (ebk)
|
020 |
|
|
|z 9781907568947
|
020 |
|
|
|z 1907568948
|
029 |
1 |
|
|a DEBBG
|b BV042032511
|
029 |
1 |
|
|a DEBSZ
|b 414179803
|
029 |
1 |
|
|a GBVCP
|b 814959709
|
029 |
1 |
|
|a AU@
|b 000054756424
|
035 |
|
|
|a (OCoLC)879653104
|z (OCoLC)864746994
|
037 |
|
|
|a CL0500000428
|b Safari Books Online
|
050 |
|
4 |
|a HD9665.5
|b .W544 2013eb
|
060 |
0 |
0 |
|a 2014 B-522
|
060 |
1 |
0 |
|a QV 35
|
082 |
0 |
4 |
|a 615.7
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Williams, David R.
|q (David Raymond),
|d 1961-
|
245 |
1 |
4 |
|a The funding of biopharmaceutical research and development /
|c David R. Williams.
|
260 |
|
|
|a Philadelphia :
|b Woodhead Pub.,
|c 2013.
|
300 |
|
|
|a 1 online resource (xxxvii, 245 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Woodhead Publishing Series in biomedicine ;
|v no. 43
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a 1. Introduction to the biopharmaceutical market -- 2. Synopsis of theories of the firm and valuation methods -- 3. Innovation and the merging of the pharmaceutical and biotechnology industries -- 4. The funding of basic research and public-private partnerships -- 5. Strategic alliances -- 6. Angel and venture capital -- 7. The initial public offering -- 8. Conclusion.
|
520 |
|
|
|a This book describes the theoretical underpinnings, present practice, and trends in R & D funding in the human biopharmaceutical market sector, both in the U.S. and worldwide. It includes a review and discussion of public-private partnership activity and their inner-workings as well as an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It includes venture capital activity and the IPO process.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a O'Reilly
|b O'Reilly Online Learning: Academic/Public Library Edition
|
650 |
|
0 |
|a Pharmaceutical industry
|x Finance.
|
650 |
|
0 |
|a Biopharmaceutics
|x Research.
|
650 |
1 |
2 |
|a Biopharmaceutics
|x economics
|
650 |
2 |
2 |
|a Biomedical Research
|
650 |
2 |
2 |
|a Drug Discovery
|x economics
|
650 |
2 |
2 |
|a Drug Industry
|x economics
|
650 |
|
6 |
|a Industrie pharmaceutique
|x Finances.
|
650 |
|
6 |
|a Biopharmacie
|x Recherche.
|
650 |
|
7 |
|a Pharmaceutical industry
|x Finance
|2 fast
|
655 |
|
4 |
|a Internet Resources.
|
776 |
0 |
8 |
|i Print version:
|a Williams, David R. (David Raymond), 1961-
|t Funding of biopharmaceutical research and development.
|d Oxford ; Philadelphia : Woodhead Publishing, 2013
|z 9781907568947
|w (DLC) 2013940431
|w (OCoLC)745979958
|
830 |
|
0 |
|a Woodhead Publishing series in biomedicine ;
|v no. 43.
|
856 |
4 |
0 |
|u https://learning.oreilly.com/library/view/~/9781907568947/?ar
|z Texto completo (Requiere registro previo con correo institucional)
|
938 |
|
|
|a Internet Archive
|b INAR
|n fundingofbiophar0000will
|
938 |
|
|
|a Cengage Learning
|b GVRL
|n GVRL8DEE
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis26861868
|
994 |
|
|
|a 92
|b IZTAP
|